sorafenib has been researched along with ly3009120 in 3 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (ly3009120) | Trials (ly3009120) | Recent Studies (post-2010) (ly3009120) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 20 | 0 | 19 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Agianian, B; Gavathiotis, E | 1 |
Abdel-Maksoud, MS; Ammar, UM; Oh, CH | 1 |
Abdel-Maksoud, MS; Ali, EMH; Ammar, UM; Mersal, KI; Oh, CH; Yoo, KH | 1 |
2 review(s) available for sorafenib and ly3009120
Article | Year |
---|---|
Current Insights of BRAF Inhibitors in Cancer.
Topics: Animals; Drug Discovery; Humans; Mutation; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf | 2018 |
Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents.
Topics: Animals; Antineoplastic Agents; Drug Discovery; Humans; MAP Kinase Signaling System; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; raf Kinases | 2018 |
1 other study(ies) available for sorafenib and ly3009120
Article | Year |
---|---|
Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridines; Pyrroles; Structure-Activity Relationship | 2020 |